title: Decay-accelerating factor transgenic mouse hearts are protected from human complement-mediated attack.
authors.affiliation: Immunology Research Centre, St. Vicent's Hospital, Fitzroy, Australia.
authors.forename: B J
authors.initials: BJ
authors.lastname: van Denderen
authors.forename: M J
authors.initials: MJ
authors.lastname: Pearse
authors.forename: A
authors.initials: A
authors.lastname: Aminian
authors.forename: W
authors.initials: W
authors.lastname: Adam
authors.forename: T A
authors.initials: TA
authors.lastname: Shinkel
authors.forename: A J
authors.initials: AJ
authors.lastname: d'Apice
mesh_terms: D000818:Animals; D018958:CD55 Antigens / Q000096:biosynthesis* / Q000235:genetics; D015932:Complement C3c / Q000032:analysis; D003165:Complement System Proteins / Q000276:immunology*; D006321:Heart; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000097:blood; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D051379:Mice; D008822:Mice, Transgenic; D009206:Myocardium / Q000276:immunology*; D010477:Perfusion
chemical_list: D018958:CD55 Antigens; D007074:Immunoglobulin G; D015932:Complement C3c; D003165:Complement System Proteins